Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, MAT

GVB Biopharma Begins Research on CBT (Cannabicitran), Unexplored Cannabinoid


LAS VEGAS, Dec. 9, 2019 /PRNewswire/ -- GVB Biopharma, a leading hemp cannabinoid producer, announced today that its research and development team has identified and isolated a previously unstudied cannabinoid called cannabicitran, or CBT. This group of scientists, comprised of alumni from the world's leading pharmaceutical companies, will be able to study the structure, function and potential benefits of CBT in extensive detail. 

GVB Biopharma's research and development team announces identification and isolation of CBT cannabinoid.

What little is known about CBT is that it is found in highest concentrations in the distillates from the Type III flowers of the cannabis plant, which have high levels of cannabidiol (CBD) and low levels of tetrahydrocannabinol (THC). However, compared to most other cannabinoids, it is found in relatively low concentrations. Chemically, CBT is classified as a diether, which means that it has the same chemical relationship with CBD as CBD has with THC. Since it has the special quality of being the last cannabinoid retained on the chromatography column that chemists use to identify compounds, chemists may be able to use CBT as a marker for the end of all the known cannabinoids identified from a sample.

Precious few research studies have been published on the health effects of CBT. One study, performed over 35 years ago by longtime cannabinoid researcher Mahmoud ElSohly, was promising: CBT was found to reduce pressure within the eyes in rabbits, making CBT a potential treatment for glaucoma and other conditions.

With their new identification and isolation of CBT, the research and development team at GVB Biopharma have unearthed this unstudied cannabinoid. These pioneering scientists are poised to significantly expand the public knowledge base on cannabicitran and get a clear-eyed view of its significance.

GVB Biopharma utilizes a commitment to exacting principles to deliver rigorously tested hemp and cannabinoid products to the discerning consumer. With its state-of-the-art facilities for hemp processing in Oregon and white-label consumer product manufacturing in Las Vegas, GVB Biopharma adheres to the highest standards of product quality. From testing the genetic stability of seeds, to verifying the cannabinoid capacity of its plants, to checking the purity of the distilled oil, the integrity of the GVB Biopharma process is reflected in every product. 

 

GVB Biopharma

SOURCE GVB Biopharma


These press releases may also interest you

at 18:19
Note: All times local   Ottawa, Ontario 11:15 a.m. The Prime Minister will address Canadians on the COVID-19 situation, and a media availability will follow. Rideau Cottage 1 Sussex Drive Notes for media: Open coverage Media are asked to arrive to...

at 17:02
Mako Medical launched a new program focused on helping seniors and those at greater risk of contracting the Coronavirus. Mako Medical is partnering with medical practices to expand services to include in-home check-ups, RX delivery, and lab draws....

at 17:01
The food recall warning issued on March 26, 2020 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Fromagerie...

at 16:19
Her Excellency the Right Honourable Julie Payette, Governor General of Canada, wishes to share the following message from Her Majesty The Queen: "As the people of Canada experience profound and rapid changes to their lives, we are all concerned...

at 15:32
VIA Rail Canada (VIA Rail) as been informed that two of its Montréal employees have tested positive for COVID-19 yesterday, April 4. One was working on board trains in the Québec City-Windsor corridor and the other was working at the ticket office at...

at 14:09
Ensuring the safety and security of Canadians is the Government of Canada's top priority. As the COVID-19 pandemic continues to evolve, Transport Canada is working with the Public Health Agency of Canada, other levels of government, transportation...



News published on 9 december 2019 at 13:15 and distributed by: